Extracellular Matrix Constituents as Integrin Ligands

  • Klaus Kühn

Abstract

Cells produce a large number of different extracellular matrix (ECM) components such as collagens, proteoglycans and glycoproteins, which form a large variety of distinct macromolecular organizations, whose bio-mechanical properties are always adapted to its special physiological function. Three typical examples are: (1) tendons, which transmit tensile forces and are built of parallel bundles of fibrils; (2) articular cartilage, adapted to withstand pressure and to absorb shocks by a network of thin fibrils whose cavities are filled with water-binding proteoglycans and hyaluronan; and (3) the sheet-like basement membranes, optimally suited as support for cells and as filter membrane. It is still not clear how the different components of the ECM interact and how the assembly into distinct macromolecular structures is controlled. It is, however, necessary that the gene expression of the ECM components is highly coordinated and that the cells synthesize and secrete the components in a distinct time course and at a correct molecular ratio.

Keywords

Coiled Coil Globular Domain Heptad Repeat Integrin Ligand Cell BioI 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. 1.
    Piez KA. Molecular and aggregate structures of the collagens. In: Piez, KA, Reddi AH, eds. Extracellular Matrix Biochemistry. New York: Elsevier, 1984: 1–39.Google Scholar
  2. 2.
    Mayne R, Burgeson RE, eds. Structure and Function of Collagen Types. San Diego: Academic Press, 1987.Google Scholar
  3. 3.
    Van der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991; 5: 2814–2823.Google Scholar
  4. 4.
    Hulmes DJS. The collagen superfamily: divers structures and assemblies. Essays Biochem 1992; 27: 49–67.PubMedGoogle Scholar
  5. 5.
    Van der Rest M, Bruckner P. Collagens: diversity at the molecular and supramolecu-lar levels. Curr Opin Struct Biol 1994; 3: 430–436.Google Scholar
  6. 6.
    Mayne R, Brewton RG. New members of the collagen superfamily. Curr Biol 1993; 5: 883–890.Google Scholar
  7. 7.
    Yurchenco PD, Birk DE, Mecham RP, eds. Extracellular Matrix Assembly and Function. San Diego: Academic Press, 1994.Google Scholar
  8. 8.
    Kadler K. Extracellular matrix 1: fibril-forming collagens. Protein Profile 1994; 1: 519–638.PubMedGoogle Scholar
  9. 9.
    Brown JC, Timpl R. The collagen super-family. Int Arch Allergy Immunol 1995; 107: 484–490.PubMedGoogle Scholar
  10. 10.
    Rich A, Crick FCH. The molecular structure of collagen. J Mol Biol 1961; 3: 483–508.PubMedGoogle Scholar
  11. 11.
    Ramachandran GN, Ramakrishnan C. Molecular structure. In: Ramachandran GN, Reddi AH, eds. Biochemistry of Collagen. New York: Plenum Press, 1976: 45–84.Google Scholar
  12. 12.
    Kühn K. Basement membrane (type IV) collagen. Matrix Biology 1994; 14: 439–445.Google Scholar
  13. 13.
    Hofmann H, Voss T, Kühn K et al. Localization of flexible sites in thread-like molecules from electron micrographs—comparison of interstitial, basement membrane and intima collagens. J Mol Biol 1984; 172: 325–343.PubMedGoogle Scholar
  14. 14.
    Kivirikko KI, Myllylä R. Post-translational processing of procollagens. Ann NY Acad Sei 1985; 460: 187–201.Google Scholar
  15. 15.
    Kuivaniemi H, Tromp G, Prockop DJ. Mutation in collagen genes: causes of rare and some common diseases in humans. FASEB J 1991; 5: 2052–2060.Google Scholar
  16. 16.
    Segal D. Polymerism of tripeptides as collagen models. VII: Synthesis and solution properties of four collagen-like polyhexa-peptides. J Mol Biol 1969; 43: 497–517.PubMedGoogle Scholar
  17. 17.
    Morris NP, Fessler LI, Weinstock A et al. Procollagen assembly and secretion in embryonic chick bone. J Biol Chem 1975; 250: 5719–5726.PubMedGoogle Scholar
  18. 18.
    Lukens LN. Time of occurrence of disulfide linking between procollagen chains. J Biol Chem 1976; 251: 3530–3538.PubMedGoogle Scholar
  19. 19.
    Bächinger HP, Fessler LI, TIMPL R et al. Chain assembly intermediate in the biosynthesis of type III procollagen in chick embryo blood vessels. J Biol Chem 1981; 256: 13193–13199.PubMedGoogle Scholar
  20. 20.
    Engel J, Prockop DJ. The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper. Ann Rev Biophys Chem 1991; 20: 137–152.Google Scholar
  21. 21.
    Prockop DJ, Hulmes DJS. Assembly of collagen fibrils de novo from soluble precursors: polymerization and copolymeriza-tion of procollagen, pN-collagen and mutated collagens. In: Yurchenco PD, Birk DE, Mecham RP, eds. Extracellular Matrix Assembly and Structure. San Diego: Academic Press, 1994: 47–90.Google Scholar
  22. 22.
    Birk DE, Linsenmayer TF. Collagen fibril assembly, deposition and organization into tissue-specific matrices. In: Yurchenco PD, Birk DE, Mecham RP, eds. Extracellular Matrix Assembly and Structure. San Diego: Academic Press, 1994: 91–128.Google Scholar
  23. 23.
    Kühn K. The classical collagens: types I II and III. In: Mayne R, Burgeson RE, eds. Structure and Function of Collagen Types. San Diego: Academic Press, 1987: 1–42.Google Scholar
  24. 24.
    Fleischmajer R, Olsen BR, Timpl R et al. Collagen fibril formation during embryo-genesis. Cell Tiss Res 1987; 247; 105–109.Google Scholar
  25. 25.
    Gordon MK, Olsen BR. The contribution of collagenous proteins to tissue-specific matrix assemblies. Curr Opin Cell Biol 1990; 2: 833–838.PubMedGoogle Scholar
  26. 26.
    Ninomiya Y, Catagnola P, Gerecke D et al. The molecular biology of collagens with short triple-hlical domains. In: Sandell LS, Boyd CD, eds. Extracellular Matrix Genes. San Diego: Academic Press 1990: 80–114.Google Scholar
  27. 27.
    Vaughan L, Mendler M, Huber S et al. D-periodic distribution of collagen type IX along cartilage fibrils. J Cell Biol 1988; 106: 991–997.PubMedGoogle Scholar
  28. 28.
    Brewton RG, Mayne R. Heterotypic type II, IX and XI fibrils: comparison of vitreous and cartilage forms. In: Yurchenco PD, Birk DE, Mecham RP, eds. Extracellular Matrix Assembly and Structure. San Diego: Academic Press, 1994: 129–170.Google Scholar
  29. 29.
    Dublet B, Oh S, Sugrue SP et al. The structure of avian type XII collagen: al(XII) chains contain 190-kDa non-triple helical amino-13156.Google Scholar
  30. 30.
    Yurchenco PD. Assembly of laminin and type IV collagen into basement membrane networks. In: Yurchenco PD, Birk DE, Mecham RP, eds. Extracellular Matrix Assembly and Structure. San Diego: Academic Press 1994: 351–388.Google Scholar
  31. 31.
    Hudson BG, Reeders ST, Tryggvason K. Type IV collagen: structure, gene organization and role in human diseases. J Biol Chem 1993; 268: 26033–26036.PubMedGoogle Scholar
  32. 32.
    Vandenberg P, Kern A, Ries A et al. Characterization of a type IV collagen major cell binding site with affinity to the al(31 and the oc2pl integrins. J Cell Biol 1991; 113: 1475–1483.PubMedGoogle Scholar
  33. 33.
    Kern A, Eble J, Golbik R et al. Interaction of type IV collagen with the isolated integrins alpl and a2(31. Eur J Biochem 1993; 215: 151–159.PubMedGoogle Scholar
  34. 34.
    Eble JA, Golbik R, Mann K et al. The oclpl integrin recognition site of the basement membrane collagen molecule Lal(IV)]2a2(IV). EMBO J 1993; 12: 4795–4802.Google Scholar
  35. 35.
    Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J 1990; 4: 1577–1590.Google Scholar
  36. 36.
    Gerecke DR, Gordon MK, Wagman DW et al. Hemidesmosmes, anchoring filaments and anchoring fibrils: components of a unique attachment complex. In: Yurchenco PD, Birk DE, Mecham RP, eds. Extracellular Matrix Assembly and Structure. San Diego: Academic Press, 1994: 417–439.Google Scholar
  37. 37.
    Parente MG, Chung LC, Ryyannen J et al. Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. J Cell Biol 1991; 88: 6931–6935. 39Google Scholar
  38. 38.
    Burgeson RE. Laminins in epidermal structure. In: Ekblom P, Timpl R eds. The Laminins. Reading: Harwood Academic Publisher 1996: 65–96.Google Scholar
  39. 39.
    Burgeson RE, Lunstrum GP, Rokosova B et al. The structure and function of type VII collagen. In: Fleischmajer R, Olsen BR, Kiihn K, eds. Structure, Molecular Biology and Pathology of Collagen. New York: The New York Academy of Sciences, Ann NY Acad Sci 1990; 580: 32–43.Google Scholar
  40. 40.
    Timpl R, Chu ML. Microfibrillar collagen type VI. In: Yurchenco PD, Birk DE, Mecham RP, eds. Extracellular Matrix Assembly and Structure. San Diego: Academic Press, 1994: 207–242.Google Scholar
  41. 41.
    Timpl R, Engel J. Type VI collagen. In: Mayne R, Burgeson RE, eds. Structure and Function of Collagen Types. Orlando, Florida: Academic Press, 1987: 105–143.Google Scholar
  42. 42.
    Yurchenco PD, Birk DE, Mecham RP, eds. Exracellular Matrix Assembly and Structure. San Diego: Academic Press, 1994.Google Scholar
  43. 43.
    Rohrbach DH, Timpl R, eds. Molecular and Cellular Aspects of Basement Membranes. San Diego: Academic Press, 1993.Google Scholar
  44. 44.
    Ekblom P, Timpl R, eds. The Laminins. Reading: Harwood Academic Publishers, 1996.Google Scholar
  45. 45.
    Timpl, R, Brown, JC. The laminins. Matrix Biol 1994; 14: 275–281.Google Scholar
  46. 46.
    Timpl R, Brown JC. Supramolecular assembly of basement membranes. BioEssays 1996; 18: 123–132.Google Scholar
  47. 47.
    Engel J. Structure and function of laminin. In: Rohrbach DH, Timpl R, eds. Molecular and Cellular Aspects of Basement Membranes. San Diego: Academic Press, 1993: 147–176.Google Scholar
  48. 48.
    Timpl R, Rohde H, Gehron Robey P et al. Laminin—a glycoprotein from basement membranes. J Biol Chem 1979; 254: 9933–9937.PubMedGoogle Scholar
  49. 49.
    Burgeson RE, Chiquet M, Deutzmann R et al. A new nomenclature for laminins. Matrix Biol 1994; 5: 209–211.Google Scholar
  50. 50.
    Beck K, Hunter I, Engel J. Structure and function of laminin; anatomy of a multi-domain glycoprotein. FASEB J 1990; 4: 148–160.Google Scholar
  51. 51.
    Maurer P, Engel J. Structure of laminins and their chain assembly. In: Ekblom P, Timpl R, eds. The Laminins. Harwood Academic Publishers, 1996: 27–49.Google Scholar
  52. 52.
    Miner JH, Lewis RM, Sanes JR. Molecular cloning of a novel laminin chain, a5, and wide spread expression in adult mouse tissues. J Biol Chem 1995; 270: 28523–28526.PubMedGoogle Scholar
  53. 53.
    Marinkovich MP, Lunstrum GP, Burgeson RE. The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J Biol Chem 1992; 267: 17900–17906.PubMedGoogle Scholar
  54. 54.
    Marinkovich MP, Lunstrum GP, Keene DR et al. The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol 1992b; 119: 695–703.PubMedGoogle Scholar
  55. 55.
    Champliaud M-F, Lunstrum GP, Rousselle P et al. Human amnion contains a novel laminin variant, laminin 7, which like laminin 6, covalently associates with laminin 5 to promote stable epithelia-stromal attachment. J Cell Biol 1996; 132: 1189–1198.PubMedGoogle Scholar
  56. 56.
    Livanainen A, Sainio K Sariola H et al. Primary structure and expression of a novel human a4 chain. FEBSLett 1995; 365: 183–188.Google Scholar
  57. 57.
    Hunter I, Schulthess T, Engel J. Laminin chain assembly by triple and double stranded coiled-coil structures. J Biol Chem 1992; 267: 6006–6011.PubMedGoogle Scholar
  58. 58.
    Kammerer RA, Antonsson P Schulthess T et al. Selective chain recognition in the C-terminal a-helical coiled-coil region of laminin. J Mol Biol 1995; 250: 64–73.PubMedGoogle Scholar
  59. 59.
    Engel J, Efimov V, Maurer P. Domain organization of extracellular matrix proteins and their evolution. Development Suppl 1994; 120: 35–42.Google Scholar
  60. 60.
    Galliano M-F, Aberdam D Aguzzi A et al. Cloning and complete primary structure of the mouse laminin a3 chain. Distinct expression pattern of the laminin a3A and a3B chain isoforms. J Biol Chem 1995; 270: 21820–21826.PubMedGoogle Scholar
  61. 61.
    Airenne T, Haakana H, Sainio K et al. Structure of the human laminin y2 chain gene (LAMC2): alternative splicing with different tissue distribution of two transcripts. Genomics 1996; 32: 54–64.PubMedGoogle Scholar
  62. 62.
    Paulsson M. The role of Ca2+ binding in the self aggregation of laminin-nidogen complexes. J Biol Chem 1988; 263: 5425–5430.PubMedGoogle Scholar
  63. 63.
    Timpl R. Binding of laminin to extracellular matrix components. In: Ekblom P, Timpl R eds. The Laminins. Reading: Harwood Academic Publishers, 1996: 97–125.Google Scholar
  64. 64.
    Yurchenco PD, Cheng YS. Self-assembly and calcium-binding sites in laminin. A three-arm interaction model. J Biol Chem 1993; 268: 17286–17299.PubMedGoogle Scholar
  65. 65.
    Fox JW, Mayer U, Nischt R et al. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J 1991; 10: 3137–3146.Google Scholar
  66. 66.
    Mayer U, Nischt R, Pöschl E et al. A single EGF-like motif of laminin is responsible for high-affinity nidogen binding. EMBO J 1993; 12: 1879–1885.Google Scholar
  67. 67.
    Yurchenco PD, Cheng YS, Schittny JC et al. Heparin modulation of laminin polymerization. J Biol Chem 1990; 265: 3981–3991.PubMedGoogle Scholar
  68. 68.
    Carlin B, Jaffe R, Bender B et al. Entactin, a novel basal lamina associated sulfated glycoprotein. J Biol Chem 1981; 256: 5209–5214.PubMedGoogle Scholar
  69. 69.
    Timpl R, Dziadek M, Fujiwara S et al. Nidogen: A new, self-aggregating basement membrane protein. Eur J Biochem 1983; 137: 455–465.PubMedGoogle Scholar
  70. 70.
    Durkin M, Chakravarti E, Bartos S et al. Amino acid sequence and domain structure of entactin: Homology with epidermal growth factor precursor and low density lipoprotein receptor. J Cell Biol 1988; 107: 2749–2756.PubMedGoogle Scholar
  71. 71.
    Mann K, Deutzmann R, Aumailley M et al. Amino acid sequence of mouse nidogen, a multidomain basement membrane protein with binding activity for laminin, collagen IV and cells. EMBO J 1989; 8: 65–72.Google Scholar
  72. 72.
    Nagayoshi T, Sanborn D, Hickok NJ et al. Human nidogen: complete maino acid sequence and structural domains deduced from complementary DNAs, and evidence of polymorphism of the gene. DNA 1989; 8: 581–594.Google Scholar
  73. 73.
    Fox JW, Mayer U, Nischt R et al. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J 1991; 10: 3137–3146.Google Scholar
  74. 74.
    Aumailley M, Battaglia C, Mayer U et al. Nidogen mediates the formation of ternary complexes of basement membrane components. Kidney Internat 1993; 43: 7–12.Google Scholar
  75. 75.
    Brown JC, Wiedemann H, Timpl R. Protein binding and cell adhesion properties of two laminin isoforms (AmBleB2e, AmBlsB2e) from human placenta. J Cell Sci 1994; 107: 329–338.PubMedGoogle Scholar
  76. 76.
    Battaglia C, Mayer U, Aumailley M et al. Basement membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core. Eur J Biochem 1992; 208: 359–366.PubMedGoogle Scholar
  77. 77.
    Sasaki T, Gohring W. Pan TC, et al. Binding of mouse and human fibulin-2 to extracellular matrix ligands. J Mol Biol 1995; 254: 892–899.PubMedGoogle Scholar
  78. 78.
    Mayer U, Timpl R. Nidogen: a versatile binding protein of basement membranes. In: Yurchenco PD, Birk DE, Mecham RP, eds. Extracellular Matrix Assembly and Structure. Academic Press, San Diego: 389–416.Google Scholar
  79. - Chakravarti S, Tam MF, Chung AE. The basement membrane glycoprotein entactin promotes cell attachment and binds calcium ions. J Biol Chem 1990; 265: 10597–10603.PubMedGoogle Scholar
  80. 80.
    Timpl R. Binding of laminins to extracellular matrix components. In: Ekblom P, Timpl R eds. The Laminins. Reading: Harwood Academic Publishers, 1996: 97–125.Google Scholar
  81. 81.
    Mosher DF. Fibronectin. New York: Academic Press, 1989-Google Scholar
  82. 82.
    Hynes RO. Fibronectins. Berlin: Springer- Verlag, 1990.Google Scholar
  83. 83.
    Peters DMP, Mosher DF. Formation of fibronectin extracellular matrix. In: Yurchenco PP, Birk DE, Mecham RP, eds. Extracellular Matrix Assembly and Structure. San Diego: Academic Press, 1994: 315–350.Google Scholar
  84. 84.
    Ffrench-Constant C. Alternative splicing of fibronectin. Many different proteins but four different functions. Exp Cell Res 1995; 221: 261–271.PubMedGoogle Scholar
  85. 85.
    Sekiguchi K, Fukuda M, Hakomori S. Domain structure of hamster plasma fibronectin. Isolation and characterization of four functionally distinct domains and their unequal distribution between two subunit polypeptides. J Biol Chem 1981; 256; 6452–6462.PubMedGoogle Scholar
  86. 86.
    Seidl M, Hormann H. Affinity chromatography on immobilized fibrin monomer, IV. Two fibrin-binding peptides of a chymot-ryptic digest of human plasma fibronectin. Hoppe Seyler’s Z Physiol Chem 1983; 364: 83–92.PubMedGoogle Scholar
  87. 87.
    Hayashi M, Yamada KM. Divalent cation modulation of fibronectin binding to heparin and to DNA. J Biol Chem 1982; 257: 5263–5267.PubMedGoogle Scholar
  88. 88.
    Smith DE, Furcht LT. Localization of two unique heparin binding domains of human plasma fibronectin with monoclonal antibodies. J Biol Chem 1982; 257: 6518–6523.PubMedGoogle Scholar
  89. 89.
    Hayashi M, Yamada KM. Domain structure of the carboxyl-terminal half of human plasma fibronectin. J Biol Chem 1983; 258: 3332–3340.Google Scholar
  90. 90.
    Richter H, Hormann H. Early and late cathepsin D derived fragments of fibronectin containing the C-terminal interchain disulfide cross-link. Hoppe Seyler’s Z Physiol Chem 1982; 363: 351–364.PubMedGoogle Scholar
  91. 91.
    Skorstengaard K, Thogersen HC, Petersen TE. Complete primary structure of the collagen-binding domain of bovine fibronectin. Eur J Biochem 1984; 140: 235–243.PubMedGoogle Scholar
  92. 92.
    Ingham KC, Brew SA, Migliorini MM. Further localization of the gelatin-binding determinants within fibronectin. Active fragments devoid of type II homologous repeat modules. J Biol Chem 1989; 264: 16977–16980.PubMedGoogle Scholar
  93. 93.
    Skorstengaard K, Jensen MS, Petersen TE et al. Purification and complete primary structures of the heparin-, cell-, and DNA- binding domains of bovine plasma fibronectin. Eur J Biochem 1986; 154: 15–29.PubMedGoogle Scholar
  94. 94.
    Pierschbacher MD, Hayman EG, Ruoslahti E. Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule. Cell 1981; 26: 259–267.PubMedGoogle Scholar
  95. 95.
    Pierschbacher MD, Hayman EG, Ruoslahti E. Synthetic peptide with cell attachment activity of fibronectin. Proc Natl Acad Sci USA 1983; 80: 1224–1227.PubMedGoogle Scholar
  96. 96.
    Obara M, Kang MS, Yamada KM. Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function. Cell 1988; 53: 649–657.PubMedGoogle Scholar
  97. 97.
    Nagai T, Yamakama N, Aota S et al. Monoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration and matrix assembly. J Cell Biol 1991; 114: 1295–1305.PubMedGoogle Scholar
  98. 98.
    Mould AP, Komoriya A, Yamada KM et al. Affinity chromatographic isolation of the melanoma adhesion receptor for the IIICs region of fibronectin and its identification as the integrin a4(31. J Biol Chem 1991; 265: 4020–4024.Google Scholar
  99. - Hershberger RP, Culp LA. Cell-type-specific expression of alternatively spliced human fibronectin IIICS mRNAs. Mol Cell Biol 1990; 10: 662–671.PubMedGoogle Scholar
  100. 100.
    Vartio T, Laitinen L, Norvonen O et al. Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 1987; 88: 419–430.PubMedGoogle Scholar
  101. 101.
    Oyama F, Murata Y, Suganuma N et al. Patterns of alternative splicing of fibronectin pre-mRNA in human adult and fetal tissues. Biochemistry 1989; 28: 1428–1434.PubMedGoogle Scholar
  102. 102.
    Potts JR, Phan I, Williams MJ et al. High-resolution structural studies of the factor XHIa crosslinking site and the first type I module of fibronectin. Nature Struct Biol 1995; 2: 946–950.PubMedGoogle Scholar
  103. 103.
    Constantine KL, Madrid M, Banyai L et al. Refined solution structure and ligand binding properties of DDC-109 domain b. A collagen-binding type II domain. J Mol Biol 1992; 223: 281–298.PubMedGoogle Scholar
  104. 104.
    Main AL, Harvey TS, Baron M et al. The 3-dimensional structure of the 10th type- Ill module of fibronectin—an insight into RGD mediated interactions. Cell 1992; 71: 671–678.PubMedGoogle Scholar
  105. 105.
    Leaky DJ, Aukhil I, Erickson HP. 20. A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 1966; 84: 155–164.Google Scholar
  106. 106.
    Hormann H, Richter H. Models for the subunit arrangement in soluble and aggregated plasma fibronectin. Biopolymers 1986; 25: 947–958.PubMedGoogle Scholar
  107. 107.
    Ehrismann R, Roth DE, Eppenberger HM et al. Arrangement of attachment-promoting, self-association, and heparin-binding sites in horse serum fibronectin. J Biol Chem 1982; 257: 7381–7387.PubMedGoogle Scholar
  108. 108.
    Homandberg GA, Erickson JW. Model of fibronectin tertiary structure based on studies of interactions between fragments. Biochemistry 1986; 25: 6917–6925.PubMedGoogle Scholar
  109. 109.
    Jilek F, Hormann H. Fibronectin (cold-insoluble globulin) VI: influence of heparin and hyaluronic acid on the binding of native collagen. Hoppe Seyler’s Z Physil Chem 1979; 360: 597–603.Google Scholar
  110. 110.
    Vuento M, Vartio T, Saraste M et al. Spontaneous and polyamine-induced formation of filamentous polymers from soluble fibronectin. Eur J Biochem 1980; 105: 33–42.PubMedGoogle Scholar
  111. 111.
    Odermatt E, Engel J, Richter H et al. Shape, conformation and stability of fibronectin fragments determined by electron microscopy, circular dichroism and ultracentrifu-gation. J Mol Biol 1982; 159: 109–123.PubMedGoogle Scholar
  112. 112.
    McDonald JA, Ouade BJ, Broekelmann TJ et al. Fibronectin’s cell-adhesive domain and an amino terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix. J Biol Chem 1987; 262: 2957–2967.PubMedGoogle Scholar
  113. 113.
    Fogerty LFJ, Akiyama, SK, Yamada KM et al. Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (a5(31) antibodies. J Cell Biol 1990; 111: 699–708.PubMedGoogle Scholar
  114. 114.
    McKeown-Longo PJ, Mosher DF. Interaction of the 70 kilodalton amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts. J Cell Biol 1985; 100: 364–374.PubMedGoogle Scholar
  115. 115.
    Dzamba BJ, Peters DM. Arrangement of cellular fibronectin in non-collagenaous fibrils in human fibroblast cultures. J Cell Sci 1991; 100: 605–612.PubMedGoogle Scholar
  116. 116.
    Schwarzbauer JE, Mulligan RC, Hynes RO. Efficient and stable expression of recombinant fibronectin polypeptides. Proc Natl Acad Sci USA 1987; 84: 754–758.PubMedGoogle Scholar
  117. 117.
    Barry ELR, Mosher DF. Factor XHIa-medi-ated crosslinking of fibronectin at cellular matrix assembly sites. J Biol Chem 1989; 263: 10464–10469.Google Scholar
  118. 118.
    Furcht LT, Wendelschafer-Crabb G, Mosher DF et al. An axial periodic fibrillar arrangement of antigen determinants for fibronectin and procollagen on ascorbate treated human fibroblast. J Supramol Struct 1980; 13: 15–33.PubMedGoogle Scholar
  119. 119.
    Dessau W, Adelmann B, Timpl R et al. 132. Identification of the sites in collagen a chains that bind serum anti-gelatin factor (cold insoluble globulin). Biochem J 1978; 169: 55–59. 133.Google Scholar
  120. 120.
    Erickson HP. Tenascin-C, tenascin-R, and tenascin-X—a family of talented proteins in search of functions. Curr Opin Cell Biol 1993; 5: 869–876. 134.Google Scholar
  121. 121.
    Chiquet-Ehrismann R, Hagioa C, Matsumoto K. The tenascin gene family. Perspect Dev Neurobiol 1994; 2: 3–7.PubMedGoogle Scholar
  122. 122.
    Chiquet-Ehrismann R. Tenascins, a grow- 135. ing family of extracellular matrix proteins. Experientia 1995; 51: 853–862.PubMedGoogle Scholar
  123. 123.
    Spring J, Beck K, Chiquet-Ehrismann R. Two contrary functions of tenascin: dissec- 136. tion of the active sites by recombinant tenascin fragments. Cell 1989; 59: 325–334.PubMedGoogle Scholar
  124. 124.
    Chiquet-Ehrismann R. What distinguishes 137. tenascin from fibronectin? FASEB J 1990; 4: 2598–2604.Google Scholar
  125. 125.
    Aukhil I, Joshi P, Yan Y et al. Cell-and heparin-binding domains of the hexa-brachion arm identified by tenascin ex- 138. pression proteins. J Biol Chem 1993; 268: 2542–2553.PubMedGoogle Scholar
  126. 126.
    Ekblom P, Aufderheide E. Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions. Int J Biol 1989; 33: 71–79. 139.Google Scholar
  127. 127.
    Erickson HP, Bourdon MA. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. A Rev Cell Biol 1989; 5: 71–92. 140.Google Scholar
  128. 128.
    Chiquet-Ehrismann R, Matsuoka Y, Hofer U et al. Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul 1991; 2: 927–938. 141.Google Scholar
  129. 129.
    Mackie EJ, Tucker RP. Tenascin in bone morphogenesis: expression of splice variants. J Cell Sei 1992; 103: 765–771.Google Scholar
  130. 130.
    Saga Y, Yagi T, Ikawa Y et al. Mice de- 142. velop normally without tenascin. Genes Dev 1992; 6: 1821–1831.PubMedGoogle Scholar
  131. 131.
    Sriramarao P, Mendler M, Bourdon MA et al. Endothelial cell attachment and spread- 143. ing on human tenascin is mediated by oc2ßl and avß3 integrins. J Cell Sei 1993; 105: 1001–1012.Google Scholar
  132. 132.
    Prieto AL, Edelman GM, Crossink L et al. Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc Natl Acad Sei USA 1993; 90: 10154–10158.Google Scholar
  133. 133.
    Joshi P, Chung CY, Aukhil I et al. Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. J Cell Sei 1993; 106: 389–400.Google Scholar
  134. 134.
    Lochter A, Vaughan L, Kaplony A et al. Jl/ tenascin in substrate-bound and soluble form displays contrary effects on neurite outgrowth. J Cell Biol 1991; 113: 1159–1171.PubMedGoogle Scholar
  135. 135.
    Friedlander DR, Hoffman S, Edelman GM et al. Functional mapping of cytotactin: proteolytic fragments active in cell-substrate adhesion. J Cell Biol 1988; 107: 2329–2340.PubMedGoogle Scholar
  136. 136.
    Chiquet-Ehrismann R, Kalla P, Pearson CA et al. Tenascin interferes with fibronectin action. Cell 1988; 53: 383–390.PubMedGoogle Scholar
  137. 137.
    Norenberg U, Wille FI, Wolff JM et al. The chicken neural extacellular matrix molecule restrictin; similarity with EGF-, fibronectin type III-, and fibrogen-like motifs. Neuron 1992; 8: 849–863.PubMedGoogle Scholar
  138. 138.
    Fuss B, Wintergerst E, Bartsch U et al. Molecular characterization and in situ mRNA localization of the neural recognition molecule J1–160/1 80: a modular structure similar to tenascin. J Cell Biol 1993; 120: 1237–1245.PubMedGoogle Scholar
  139. 139.
    Pesheva P, Spiess E, Schachner M et al. J1–160 and J1–180 are oligodendrocyte-se-creted nonpermissive substrates for cell adhesion. J Cell Biol 1989; 109: 1765–1778.PubMedGoogle Scholar
  140. 140.
    Wintergerst ES, Fuss B, Bartsch U et al. Localization of janusin mRNA in the central nervous system of the developing and adult mouse. Eur J. Neurosci 1993; 5: 299–310.PubMedGoogle Scholar
  141. 141.
    Bartsch U, Pesheva P, Raff M et al. Expression of janusin (Jl-160/180) in the retina and optic nerve of the developing and adult mouse. Glia 1993; 9: 57–69PubMedGoogle Scholar
  142. 142.
    Gitelman SE, Bristow J, Miller WL et al. Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus. Mol Cell Biol 1992; 12: 3313–3314.PubMedGoogle Scholar
  143. 143.
    Matsumoto K, Arai M, Ishihara N et al. Cluster of fibronectin type III repeats found in the human major histocompatibility complex class III region shows the highest homology with the repeats in an extracellular matrix protein, tenascin. Genomics 1992; 12: 485–491.PubMedGoogle Scholar
  144. 144.
    Matsumoto K, Saga Y, Ikemura T et al. The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J Cell Biol 1994; 125: 483–493.PubMedGoogle Scholar
  145. 145.
    Low FN. Microfibrils: fine filamentous components of the tissue space. Anat Rec 1962; 142: 131–137.PubMedGoogle Scholar
  146. 146.
    Cleary EG, Gibjson MA. Elastin associated microfibrils and micro-fibrillar proteins. Int Rev Connect Tissue Res 1983; 10: 97–210.PubMedGoogle Scholar
  147. 147.
    Maslen CL, Corson GM, Maddox BK et al. cDNA cloning and partial sequence determination of human fibrillin, a candidate gene for the Marfan Syndrome. Nature 1991; 352: 334–337.PubMedGoogle Scholar
  148. 148.
    Lee B, Godfrey M, Vitale E et al. Linkage of Marfan Syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 1991; 352: 330–334.PubMedGoogle Scholar
  149. 149.
    Corson GM, Chalberg SC, Dietz HC et al. Fibrillin binds calcium and is encoded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5’ end. Genomics 1993; 17: 468–475.PubMedGoogle Scholar
  150. 150.
    Pereira L, D’Alessio M, Ramirez F et al. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet 1993; 2: 961–968.PubMedGoogle Scholar
  151. 151.
    Zhang H, Apfelroth SD, Hu W et al. Structure and function of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol 1994; 124: 855–863.PubMedGoogle Scholar
  152. 152.
    Davis EC. Immuno localization of microfibril and microfibril-associated proteins in the subendothelial matrix of the developing mouse aorta. J Cell Sci 1994; 107: 727–736.PubMedGoogle Scholar
  153. 153.
    Leak LV, Burke JF. Electron microscopic study of lymphatic capillaries in the removal of conective tissue fluids and particulate substances. Lymphology 1968; 1: 39–52.PubMedGoogle Scholar
  154. 154.
    Gerli R, Ibba L, Fruschelli C. A fibrillar elastic apparatus around human lymph-capillaries. Anat Embryol 1990; 181: 281–286.PubMedGoogle Scholar
  155. 155.
    Davis EC. Smooth muscle cell to elastic lamina connections in developing mouse aorta. Role in aortic medial organization. Lab Invest 1993; 68: 89–99.PubMedGoogle Scholar
  156. 156.
    Cotta-Pereira G, Rodrigo FG, Bittencourt- Sampaio S. Oxytalan, elaunin, and elastic fibers in the human skin. J Invest Dermatol 1976; 66: 143–148.PubMedGoogle Scholar
  157. 157.
    Dahlback K, Ljungquist A, Löfberg H et al. Fibrillin immuno reactive fibers constitute a unique network in the human dermis: immuno-histochemical comparison of the distribution of fibrillin to fibronectin. J Invest Dermatol 1990; 94: 284–291.PubMedGoogle Scholar
  158. 158.
    Kielty CM, Whittaker SP, Grant ME. Attachment of human vascular smooth muscle cells to intact microfibrillar assemblies of collagen VI and fibrillin. J Cell Sci 1992; 103: 445–451.PubMedGoogle Scholar
  159. 159.
    Mecham RP, Heuser JE. The elastic fiber. In: Hay ED, ed. Cell Biology of the Extracellular Matrix, 2nd edn. New York: Plenum Publishing Co, 1991: 79–109.Google Scholar
  160. 160.
    Gibson MA, Sandberg LB, Grosso LE et al. Complementary DNA cloning establishes microfibril-associated glycoprotein (MAGP) to be a discrete component of elastin-asso-ciated microfibrils. J Biol Chem 1991; 266: 7596–7601.PubMedGoogle Scholar
  161. 161.
    Horrigan SK, Rich CB, Streeten BW et al. Characterization of an associated microfibril protein through recombinant DNA techniques. J Biol Chem 1992; 267: 10087–10095.PubMedGoogle Scholar
  162. 162.
    Lee B, Godfrey M, Vitale E et al. Linkage of Marfan syndrome and a phenotypically related disorder to two fibrillin genes. Nature 1991; 352: 330–334.PubMedGoogle Scholar
  163. 163.
    Ramirez F, Pereira L, Zhang H et al. The fibrillin-Marfan syndrome connection. BioEssays 1993; 15: 589–594.Google Scholar
  164. 164.
    Sakai LY. Disulfide bonds crosslink molecules of fibrillin in the connective tissue space. In: Tamburro A, Davidson J, eds. Elastin: Chemical and Biological Aspects. Galatina, Italy: Congedo Editore.Google Scholar
  165. 165.
    Keene DR, Maddox BK, Kuo HJ et al. Extraction of extendable beaded structures and their identification as fibrillin containing extracelular matrix microfibrils. J Histochem Cytochem 1991; 39: 441–449.PubMedGoogle Scholar
  166. 166.
    Pfaff M, Reinhardt DP, Sakai LY et al. Cell adhesion and integrin binding to recombi-nant human fibrillin-1. FEBS Letters 1996; 384: 247–250.PubMedGoogle Scholar
  167. 167.
    Argraves WS, Tran H, Burgess WH et al. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J Cell Biol 1990; 111: 3155–3164.PubMedGoogle Scholar
  168. 168.
    Pan TC, Kluge M, Zhang RZ et al. Sequence of extracellular mouse protein BM- 90/fibulin and its calcium-dependent binding to other basement membrane ligands. Eur J Biochem 1993a; 215: 733–740.PubMedGoogle Scholar
  169. 169.
    Pan TC, Sasaki T, Zhang RZ et al. Structure and expression of fibulin-2, a novel extracellular matriy protein with multiple EGF-like repeats and consensus motifs for calcium-binding. J Cell Biol 1993b; 123: 1269–1277.PubMedGoogle Scholar
  170. 170.
    Zhang RZ, Pan TC, Zhang CY et al. Fibulin-2 (FBLN2): human cDNA sequence, mRNA expression and mapping of the gene on human and mouse chromosomes. Genomics 1994; 22: 425–430.PubMedGoogle Scholar
  171. 171.
    Sasaki T, Kostka G, Göhring W et al. Structural characterization of two variants of fibulin-1 that differ in nidogen affinity. J Mol Biol 1995; 245: 241–250.PubMedGoogle Scholar
  172. 172.
    Kluge M, Mann K, Dziadek M et al. Characterization of a novel calcium-binding 90- kDa glycoprotein (BM-90) shared by basement membranes and serum. Eur J Biochem 1990; 193: 651–659.PubMedGoogle Scholar
  173. 173.
    Spence SG, Argraves WS, Walters L et al. Fibulin is localized at sites of epithelialmesenchymal transitions in the early avian embryo. Dev Biol 1992; 151: 473–484.PubMedGoogle Scholar
  174. 174.
    Zhang HY, Kluge M, Timpl R et al. The extracellular matrix glycoproteins BM-90 and tenascin are expressed in the messen-chyme at sites of endothelial-mesenchymal conversion in the embryonic mouse heart. Differentiation 1993; 52: 211–220.PubMedGoogle Scholar
  175. 175.
    Zhang HY, Chu ML, Pan TC et al. Extracellular matrix protein fibulin-2 is expressed in the embryonic endocardium cushion tissue and is a prominent component of valves in adult heart. Dev Biol 1995; 167: 18–26.PubMedGoogle Scholar
  176. 176.
    Zhang HY, Timpl R, Sasaki T et al. Fibulin-1 and fibulin-2 expression during organogenesis in the developing mouse embryo. Dev Dynamics 1996; 205: 348–364.Google Scholar
  177. 177.
    Balbona K, Tran H, Godyna S et al. Fibulin binds to itself and to the carboxyl-terminal heparin-binding region of fibronectin. J Biol Chem 1992; 267: 20120–20125.PubMedGoogle Scholar
  178. 178.
    Sasaki T, Gohring W, Pan TC et al. Binding of mouse and human fibulin-2 to extracellular matrix ligands. J Mol Biol 1995; 254: 892–899.PubMedGoogle Scholar
  179. 179.
    Pfaff M, Sasaki T, Tangemann K et al. Integrin-binding and cell-adhesion studies of fibulins reveal a particular affinity for allbp3. Exp Cell Res 1995; 219: 87–92.PubMedGoogle Scholar
  180. 180.
    Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB 1993; 7: 1475–1482.Google Scholar
  181. 181.
    Franzen A, Heinegard D. Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 1985; 232: 715–724.PubMedGoogle Scholar
  182. 182.
    Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoproteine (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad So 1986; 83: 8819–8823.Google Scholar
  183. 183.
    Heinegard D, Hultenby K, Oldberg A et al. Macromolecules in bone matrix. Connect Tissue Res 1989; 21: 3–11.PubMedGoogle Scholar
  184. 184.
    Young MF, Kerr JM, Ibaraki K et al. Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop 1992: 275–294.Google Scholar
  185. 185.
    Nomura S, Wills AJ, Edwards DR et al. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 1988; 106: 441–450.PubMedGoogle Scholar
  186. 186.
    Butler WT. The nature and significance of osteopontin. Connect Tissue Res 1989; 23: 123–136.PubMedGoogle Scholar
  187. 187.
    Reinholt FP, Hultenby K, Oldberg A et al. Osteopontin—a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 1990; 87: 4473–4475.PubMedGoogle Scholar
  188. 188.
    Miyauchi A, Alvarez J, Greenfield EM et al. Recognition of osteopontin and related peptides by an av(33 integrin simulates immediate cell signals in osteoclasts. J Biol Chem 1991Google Scholar
  189. 189.
    Oldberg A, Franzen A, Heinegard D. The primary sructure of a cell-binding bone sialoprotein. J Biol Chem 1988; 263: 19430–19432.PubMedGoogle Scholar
  190. 190.
    Fisher LW, McBride OW, Termine JD et al. Human bone sialoprotein. Deduced protein sequence and chromosomal localization. J Biol Chem 1990; 265: 4: 2347–2351.PubMedGoogle Scholar
  191. 191.
    Midura RJ, McQuillan DJ, Benham KJ et al. A rat osteogenic cell line (UMR 106–01) synthesizes a highly sulfated form of bone sialoprotein. J Biol Chem 1990; 265: 5285–5291.PubMedGoogle Scholar
  192. 192.
    Fisher LW, Hawkins GR, Tuross N et al. Purification and partial characterization of small proteoglycans I and II, bone sialo-proteins I and II and osteonectin from the mineral compartment of developing human bone. J Biol Chem 1987; 262: 9702–9708.PubMedGoogle Scholar
  193. 193.
    Hunter GK, Goldberg HA. Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci USA 1993; 90: 8562–8565.PubMedGoogle Scholar
  194. 194.
    Chen J, Shapiro HS, Sodek J. Development expression of bone sialoprotein mRNA in rat mineralized connective tissues. J Bone Miner Res 1992; 7: 987–997.PubMedGoogle Scholar
  195. 195.
    Heinegard D, Oldberg A. Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J 1989; 3: 2042–2051.Google Scholar
  196. 196.
    Hardingham TE, Fosang AJ. Proteoglycans: man forms and many functions. FASEB J 1992; 6: 861–870.Google Scholar
  197. 197.
    Heinegard D, Oldberg A. Glycosylated matrix proteins. Connective Tissue and its Heritable Disorders 1993; chapter 5, 189–209.Google Scholar
  198. 198.
    Hayashi K, Madri JA, Yurchenco PD. Endothelial cells interact with the coprotein of basement membrane perlecan through (31 and (33 integrins: an adhesion modulated by glycosaminoglycan. J Cell Biol 1992; 119: 945–959.PubMedGoogle Scholar
  199. 199.
    Timpl R. Proteoglycans of basement membranes. Experientia 1993; 49: 417–428.PubMedGoogle Scholar
  200. 200.
    Noonan DM, Horigan E, Ledbetter S et al. Identification of cDNA clones encoding different domains of the basement membrane heparin sulfate proteoglycan. J Biol Chem 1988; 263: 16379–16387.PubMedGoogle Scholar
  201. 201.
    Noonan D, Fulle A, Valente P et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 1991; 266: 22939–22947.PubMedGoogle Scholar
  202. 202.
    Murdoch AD, Dodge GR, Cohen I et al. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric collagen with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules and epidermal growth factor. J Biol Chem. 1992; 267: 8544–8557.PubMedGoogle Scholar
  203. 203.
    Kallunki P, Tryggvason K. Human basement membrane heparan sulfate proteoglycan core protein: a 467-kDa protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules and epidermal growth factor. J Cell Biol 1992; 116: 559–571.PubMedGoogle Scholar
  204. 204.
    Timpl R, Brown JC. Supramolecular assembly of basement membranes. BioEssays 1996; 18: 123–132.Google Scholar
  205. 205.
    Farquhar MG. The glomerular basement membrane. A selective macromolecular filter. In: Hay ED, ed. Cell Biology of Extracellular Matrix. New York: Plenum, 1991: 365–418.Google Scholar
  206. 206.
    Yurchenco PD, Cheng Y-S, Ruben GC. Self-assembly of high molecular weight basement membrane heparan sulfate proteoglycan into dimers and oligomers. J Biol Chem 1987; 262: 17668–17676.PubMedGoogle Scholar
  207. 207.
    Chakravarti S, Horchar T, Jeffeson B. Recombinant domain III of perlecan promotes cell attachment through its RGD sequence. J Biol Chem 1995; 270; 404–409.PubMedGoogle Scholar
  208. 208.
    Bale MD, Wohlfahrt LA, Mosher DF et al. Identification of vitronectin as a major plasma protein absorbed on polymer surfaces of different copolymer composition. Blood 1989; 74: 2698–2706.PubMedGoogle Scholar
  209. 209.
    Tomasini BR, Mosher DF. Vitronectin. Prog Hemost Thromb 1991; 10: 269–305.Google Scholar
  210. 210.
    Preissner KT. Structure and biological role of vitronectin. Ann Rev Cell Biol 1991; 7: 275–310.PubMedGoogle Scholar
  211. 211.
    Preissner KT, Rosenblatt S, Kost C et al, eds. Biology of Vitronectins and Their Receptors. Amsterdam, New York, London, Tokyo: Exerpta Medica 1993.Google Scholar
  212. 212.
    Suzuki S, Oldberg A, Hayman EG et al. Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBOJ 1985; 4: 2519–2524.Google Scholar
  213. 213.
    Jenne D, Stanley KK. Nucleotide sequence and organization of the human S-protein gene: repeating peptide motifs in the “pexin” family and a model for their evolution. Biochemistry 1987; 26: 6735–6742.PubMedGoogle Scholar
  214. 214.
    Sato R, Komine Y, Imanaka T et al. Monoclonal antibody EMR Ia/212D recognizing site of deposition of extracellular lipid in atherosclerosis. Isolation and characterization of a cDNA clone for the antigen. J Biol Chem 1990; 265: 21232–21236.PubMedGoogle Scholar
  215. 215.
    Seiffert D, Keeton M, Eguchi Y et al. Detection of vitronectin mRNA in tissues and cells of the mouse. Proc Natl Acad Sci USA 1991; 88: 9402–9406.PubMedGoogle Scholar
  216. 216.
    Kubota K, Katayama S, Matsuda M et al. Three types of vitronectin in human blood. Cell Struct 1988; 13: 123–128.Google Scholar
  217. 217.
    Patthy L. Detecting distant homologies of mosaic proteins. Analysis of the sequences of thrombomodulin, thrombospondin complement components C9, C8-a and C8-(3, vitronectin and plasma cell membrane glycoprotein PC-I. J Mol Biol 1988; 202: 689–696.Google Scholar
  218. 218.
    Gebb C, Hayman EG, Engvall E et al. Interaction of vitronectin with collagen. J Biol Chem 1986; 261: 16698–16703.PubMedGoogle Scholar
  219. 219.
    Izumi M, Shimo-Oka T, Morishita N et al. Identification of the collagen-binding domain of vitronectin using monoclonal antibodies. Cell Struct Funct 1988; 13: 217–225.PubMedGoogle Scholar
  220. 220.
    Preissner KT, Miiller-Berghaus G. Neutralization and binding of heparin by S pro-tein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin binding domain of S pro-tein/vitronectin. J Biol Chem 1987; 262: 12247–12253.PubMedGoogle Scholar
  221. 221.
    Hunt LT, Barker WC, Chen HR. A domain structure common to hemopexin, vitronectin, interstitial collagenase, and a collagenase homolog. Prot Seq Data Anal 1987; 1: 21–26.Google Scholar
  222. 222.
    Izumi M, Yamada KM, Hayashi M. Vitronectin exists in two structurally and functionally distinct forms in human plasma. Biochim Biophys Acata 1989; 990: 101–108.Google Scholar
  223. 223.
    Hess S, Stockmann A, Volker W et al. Multimeric vitronectin: structure and function. In: Preissner KT, Rosenblatt S, Kost C et al. eds. Biology of Vitronectins and Their Receptors. Excerpta Medica, 1993: 21–29.Google Scholar
  224. 224.
    Sane DC, Moser TL, Parker CJ et al. Highly sulfated glycosaminoglycans augment the cross-linking of vitronectin by guinea pig liver transglutaminase. Functional studies of the cross-linked vitronectin multimers. J Biol Chem 1990; 265: 3543–3548.PubMedGoogle Scholar
  225. 225.
    Dejana E, Colella S, Conforti G et al. Fibronectin and vitronectin regulate the organization of their respective Arg-Gly-Asp adhesion receptors in cultured human endothelial cells. J Cell Biol 1988; 107: 1215–1223.PubMedGoogle Scholar
  226. 226.
    Singer II, Kawka DW, Scott S et al. The fibronectin cell attachment sequence Arg- Gly-Asp-Ser promotes focal contact formation during early fibroblast attachment and spreading. J Cell Biol 1987; 104: 573–584.PubMedGoogle Scholar
  227. 227.
    Huang S, Mulvihill ER, Farrell DH et al. Biosynthesis of human fibrinogen. J Biol Chem 1993; 268: 8919–8926.PubMedGoogle Scholar
  228. 228.
    Chung DW, Davie EW. Gamma and gamma’ chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984; 23: 4232–4236.PubMedGoogle Scholar
  229. 229.
    Haidaris PJ, Peerschke EIB, Marder VJ et al. The C-terminal sequence of gamma 57.5 chain of human fibrinogen constitute a plasmin sensitive eopitope that is exposed in X-linking fibrin. Blood 1989; 74: 2437–2444.PubMedGoogle Scholar
  230. 230.
    Doolittle RF, Goldbaum DM, Doolittle LR. Designation of sequences involved in the “coiled-coil” interdomainal connections in fibrinogen: construction of an atomic scale model. J Mol Biol 1978; 120: 31 1–325.Google Scholar
  231. 231.
    Huang S, Cao Z, Davie EW. The role of amino-terminal disulfide bonds in the structure and assembly of human fibrinogen. Biochem Biophys ResComm 1993; 190: 488–495.Google Scholar
  232. 232.
    Veklich YI, Gorkun OV, Medved LV et al. Carboxyl-terminal portions of the a chains of fibrinogen and fibrin. J Biol Chem 1993; 268: 13577–13585.PubMedGoogle Scholar
  233. 233.
    Lewis SD, Shields PP, Shafer JA. Characterization of the kinetic pathway for liberation of fibrino peptides during assembly of fibrin J Biol Chem 1985; 260: 10192–10199.Google Scholar
  234. 234.
    Laudano AP, Doolittle RF. Influence of calcium ion on the binding of fibrin amino terminal peptides to fibrinogen. Science 1981; 212: 457–459.PubMedGoogle Scholar
  235. 235.
    Doolittle RF. Fibrinogen and fibrin. Annu Rev Biochem 1984; 53: 195–229.PubMedGoogle Scholar
  236. 236.
    Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure on fibrinolysis. J Biol Chem 1992; 267: 24259–24263.PubMedGoogle Scholar
  237. 237.
    Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function through adhesion receptors: a dual role for Gly-coprotein Ilb-IIIa (integrin odIbß3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 1992; 267: 11300–11306.PubMedGoogle Scholar
  238. 238.
    Savage B, Ruggeri ZM. Selective recognition of adhesive sites in surface-bound fibrinogen by GP IIb -Ilia on non-activated platelets. J Biol Chem 1991; 266: 11227–11233.PubMedGoogle Scholar
  239. 239.
    Farrell DH, Thiagarajan P, Chung DW et al. Role of fibrinogen a and y chain sites in platelet aggregation. Proc Natl Acad Sei USA 1992; 89: 10729–10732.Google Scholar
  240. 240.
    Hawiger J, Timmons S. Binding of fibrinogen and von Willebrand factor to platelet glycoprotein Ilb-IIIa complex. Methods in Enzymology 1992; 215: 228–232.PubMedGoogle Scholar
  241. 241.
    Lawler J, Duquette M, Urry L et al. The evolution of the thrombospondin gene family. J Mol Evol 1993; 36: 509–516PubMedGoogle Scholar
  242. 242.
    Oldberg A, Antonsson P, Lindblom K et al. COMP is structurally related to the thrombospondins. J Biol Chem 1992; 267: 2246–22350.Google Scholar
  243. 243.
    Bornstein P. Thrombospondins: structure and regulation of expression. FASEB J 1992; 6: 3290–3299.Google Scholar
  244. 244.
    Adams JC, Lawler J. The thrombospondin family. Curr Biol 1993; 3: 188–190.PubMedGoogle Scholar
  245. 245.
    Kosfeld MD, Pavlopoulos TV, Frazier WA. Cell attachment activity of the carboxy-ter-minal domain of human thrombospondin expressed in Escherichia coli. J Biol ChemGoogle Scholar
  246. 1991;.
    :24257–24259-Google Scholar
  247. 246.
    Lawler J, Weinstein R, Hynes RO. Cel attachment to thrombospondin: the role of Arg-Gly-Asp, calcium, and integrin receptors. J Cell Biol 1988; 107: 2351–2361.PubMedGoogle Scholar
  248. 247.
    Lawler J, Hynes RO. An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin. Blood 1989; 74: 2022–2027.PubMedGoogle Scholar
  249. 248.
    Karczewski J, Knudsen KA, Smith L et al. The interaction of thrombospondin with platelet glycoprotein GPIIb-IIIa. J Biol Chem 1989; 264: 21322–21326.PubMedGoogle Scholar
  250. 249.
    Stomski FC, Gani J, Bates RC et al. Adhesion to thrombospondin by human embryonic fibroblasts is mediated by multiple receptors and includes a role for glycoprotein 88 (CD36). Exp Cell Res 1992; 198: 85–92.PubMedGoogle Scholar
  251. 250.
    Tolsma SS, Volpert OV, Good DJ et al. Peptides derived from separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993; 122: 497–511.PubMedGoogle Scholar
  252. 251.
    Schultz-Cherry S, Lawler J, Murphy-Ullrich JE. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-p. J Biol Chem 1994; 269: 26783–26788.PubMedGoogle Scholar
  253. 252.
    Laherty CP, O’Rourke K, Wolfe FW et al. Characterization of mouse thrombospondin 2 sequence and expression during cell growth and development. J Biol Chem 1992; 267: 3274–3281.PubMedGoogle Scholar
  254. 253.
    Vos HL, Deveryalu S, Vries Y et al. Thrombospondin 3 (Thbs3), a new member of the thrombospondin gene family. J Biol Chem 1992; 267: 12192–12196.PubMedGoogle Scholar
  255. 254.
    Lawler J, Duquette M, Whittaker CA et al. Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family. J Cell Biol 1993; 120: 1059–1067.PubMedGoogle Scholar
  256. 255.
    Qabar A, Derick L, Lawler J et al. Thrombospondin 3 is a pentameric molecule held together by interchain disulfide linkage involving two cysteine residues. J Biol Chem 1995; 270: 12725–12729.PubMedGoogle Scholar
  257. 256.
    Lawler J, McHenry K, Duquette M et al. Characterization of human thrombospondin- 4. J Biol Chem 1995; 270: 2809–2814.PubMedGoogle Scholar
  258. 257.
    Morgelin M, Heinegard D, Engel J et al. Electron microscopy of native cartilage oligomerica matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. J Biol Chem 1992; 267: 6137–6141.PubMedGoogle Scholar
  259. 258.
    Qabar AN, Lin Z, Wolf FW et al. Thrombospondin 3 is a developmentally regulated heparin binding protein. J Biol Chem 1994; 269: 1262–1269.PubMedGoogle Scholar
  260. 259.
    Arber S, Caroni P. Thrombospondin-4, an extracellular matrix protein expressed in the developing and adult nervous system promotes neurite outgrowth. J Cell Biol 1995; 131: 1083–1094.PubMedGoogle Scholar
  261. 260.
    Ruggeri ZM, Ware J. von Willebrand factor. FASEB J 1993; 7: 308–316.Google Scholar
  262. 261.
    Ruggeri ZM. von Willebrand factor and fibrinogen. Curr Opinion Cell Biol 1993; 5: 898–906.Google Scholar
  263. 262.
    Bonthron DT, Handin RI, Kaufman RJ et al. Structure of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature (London) 1986; 324: 270–273.Google Scholar
  264. 263.
    Shelton-Inloes BB, Titani K, Sadler JE. cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms. Biochemistry 1986; 25: 3164–3171.PubMedGoogle Scholar
  265. 264.
    Fay PJ, Kawai Y, Wagner DD et al. Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science 1986; 232: 995–998.PubMedGoogle Scholar
  266. 265.
    Takagi J, Fujisawa T, Sekiya F et al. Collagen-binding domain within bovine propolypeptide of von Willebrand factor. J Biol Chem 1991; 266:5575–5579-Google Scholar
  267. 266.
    Mayadas TN, Wagner DD. von Willebrand factor biosynthesis and processing. Ann N Y Acad Sci 1991; 614: 153–166.PubMedGoogle Scholar
  268. 267.
    Voorberg J, Fontijn R, Calafat J et al. Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids. J Cell Biol 1991; 113: 195–205.PubMedGoogle Scholar
  269. 268.
    Wise RJ, Pittman DD, Handin RI et al. The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell 1988; 52: 229–236.PubMedGoogle Scholar
  270. 269.
    Turitto VT, Weiss HJ, Zimmerman TS et al. Factor VHI/von Willebrand factor in subendothelium mediates platelet adhesion. Blood 1985; 65: 823–831.PubMedGoogle Scholar
  271. 270.
    Ware J, Dent JA, Azuma H et al. Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet GP Ib-IX receptor. Proc Natl Acad Sci USA 1991; 88: 2946–2950.PubMedGoogle Scholar
  272. 271.
    Berliner S, Niiya K, Roberts JR et al. Generation and characterization of peptide-spe-cific antibodies that inhibit von Willebrand factor binding to glycoprotein Ilb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro 1743 and other amino acid residues adjacent to the sequence Argl744-Gly 1745-Aspl746. J Biol Chem 1988; 263: 7500–7505.PubMedGoogle Scholar
  273. 272.
    Dejana E, Lampugnani MG, Giorgi M et al. Von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism. J Cell Biol 1989; 109: 367–375.PubMedGoogle Scholar
  274. 273.
    Sugimoto M, Mohri H, McClintock RA et al. Identification of discontinuous von Willebrand factor sequences involved in complex formation with Botrocetin: a model for the regulation of von Willebrand factor binding to platelet glycoprotein lb. J Biol Chem 1991; 266: 18172–18178.PubMedGoogle Scholar
  275. 274.
    Mohri H, Fujimura Y, Shima M et al. Structure of the von Willebrand factor domain interacting with glycoprotein lb. J Biol Chem 1988; 263: 17901–17904.PubMedGoogle Scholar
  276. 275.
    Roth GJ, Titani K, Hoyer LW et al. Localization of binding sites within human von Willebrand factor for monomeric type III collagen. Biochemistry 1986; 25: 8357–8361.PubMedGoogle Scholar
  277. 276.
    Pareti FI, Niiya K, McPherson JM et al. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. J Biol Chem. 1987; 262: 13835–13841.PubMedGoogle Scholar
  278. 277.
    Mohri H, Yoshioka A, Zimmerman TS et al. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein lb, heparin, and collagen, and characterization of its three distinct functional sites. J Biol Chem. 1989; 264: 17361–17367.PubMedGoogle Scholar
  279. 278.
    Colombatti A, Bonaldo P. The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemo-stasis, cellular adhesion, and defence mechanisms. Blood 1991; 77: 2305–2315.PubMedGoogle Scholar
  280. 279.
    Tuckwell DS, Calderwood DA, Green LJ et al. Integrin a2I-domain is a binding site for col-lagens. J Cell Sci 1995; 108: 1629–1637.PubMedGoogle Scholar
  281. 280.
    Hunt LT, Barker WC. von Willebrand factor shares a distinctive cysteine-rich domain with thrombospondin and procollagen. Biochem Biophys Res Commun 1987; 144: 876–882.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1997

Authors and Affiliations

  • Klaus Kühn

There are no affiliations available

Personalised recommendations